These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 16709303

  • 1. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study.
    Lundborg M, Wille S, Bjermer L, Tilling B, Lundgren M, Telg G, Ekström T, Selroos O.
    Curr Med Res Opin; 2006 May; 22(5):809-21. PubMed ID: 16709303
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark--cost-effectiveness analysis based on five randomised controlled trials.
    Wickstrøm J, Dam N, Malmberg I, Hansen BB, Lange P.
    Clin Respir J; 2009 Jul; 3(3):169-80. PubMed ID: 20298400
    [Abstract] [Full Text] [Related]

  • 3. A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma.
    Ställberg B, Ekström T, Neij F, Olsson P, Skoogh BE, Wennergren G, Löfdahl CG, SHARE trial group.
    Respir Med; 2008 Oct; 102(10):1360-70. PubMed ID: 18723335
    [Abstract] [Full Text] [Related]

  • 4. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice.
    Goossens LM, Riemersma RA, Postma DS, van der Molen T, Rutten-van Mölken MP.
    Adv Ther; 2009 Sep; 26(9):872-85. PubMed ID: 19768640
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy.
    Price D, Wirén A, Kuna P.
    Allergy; 2007 Oct; 62(10):1189-98. PubMed ID: 17845590
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C.
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [Abstract] [Full Text] [Related]

  • 7. Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation.
    Miller E, FitzGerald JM.
    Can J Clin Pharmacol; 2008 Sep; 15(2):e165-76. PubMed ID: 18515918
    [Abstract] [Full Text] [Related]

  • 8. Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study.
    van Schayck OC, Haughney J, Aubier M, Selroos O, Ekström T, Ostinelli J, Buhl R.
    Respir Med; 2012 Feb; 106(2):189-96. PubMed ID: 22119455
    [Abstract] [Full Text] [Related]

  • 9. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results.
    Atienza T, Aquino T, Fernández M, Boonsawat W, Kawai M, Kudo T, Ekelund J, Ivanov S, Carlsson LG.
    Respirology; 2013 Feb; 18(2):354-63. PubMed ID: 23126237
    [Abstract] [Full Text] [Related]

  • 10. An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study.
    Price D, Haughney J, Lloyd A, Hutchinson J, Plumb J.
    Curr Med Res Opin; 2004 Oct; 20(10):1671-9. PubMed ID: 15462701
    [Abstract] [Full Text] [Related]

  • 11. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J, Boulet LP, Peters MJ, Magnussen H, Quiralte J, Martinez-Aguilar NE, Carlsheimer A.
    Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
    [Abstract] [Full Text] [Related]

  • 12. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R, Backer V, Kava TT, Omenaas ER, Sandström T, Jorup C, Welte T.
    Curr Med Res Opin; 2004 Dec; 20(2):225-40. PubMed ID: 15006018
    [Abstract] [Full Text] [Related]

  • 13. Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?
    Aubier M, Haughney J, Selroos O, van Schayck OC, Ekström T, Ostinelli J, Buhl R.
    Ther Adv Respir Dis; 2011 Oct; 5(5):289-98. PubMed ID: 21586508
    [Abstract] [Full Text] [Related]

  • 14. Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma.
    Sears MR, Boulet LP, Laviolette M, Fitzgerald JM, Bai TR, Kaplan A, Smiljanic-Georgijev N, Lee JS.
    Eur Respir J; 2008 May; 31(5):982-9. PubMed ID: 18216054
    [Abstract] [Full Text] [Related]

  • 15. A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain.
    Quirce S, Barcina C, Plaza V, Calvo E, Muñoz M, Ampudia R, Capel M.
    J Asthma; 2011 Oct; 48(8):839-47. PubMed ID: 21942354
    [Abstract] [Full Text] [Related]

  • 16. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S, Vogelmeier C, Buhl R.
    Med Klin (Munich); 2008 May 15; 103(5):299-310. PubMed ID: 18484216
    [Abstract] [Full Text] [Related]

  • 17. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma.
    Buhl R, Vogelmeier C.
    Curr Med Res Opin; 2007 Aug 15; 23(8):1867-78. PubMed ID: 17605896
    [Abstract] [Full Text] [Related]

  • 18. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma.
    Johansson G, Andreasson EB, Larsson PE, Vogelmeier CF.
    Pharmacoeconomics; 2006 Aug 15; 24(7):695-708. PubMed ID: 16802845
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma.
    Jenkins C, Kolarikova R, Kuna P, Caillaud D, Sanchis J, Popp W, Pettersson E.
    Respirology; 2006 May 15; 11(3):276-86. PubMed ID: 16635085
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.
    Patel M, Pilcher J, Pritchard A, Perrin K, Travers J, Shaw D, Holt S, Harwood M, Black P, Weatherall M, Beasley R, SMART Study Group.
    Lancet Respir Med; 2013 Mar 15; 1(1):32-42. PubMed ID: 24321802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.